Your browser doesn't support javascript.
loading
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.
Curti, Brendan D; Koguchi, Yoshinobu; Leidner, Rom S; Rolig, Annah S; Sturgill, Elizabeth R; Sun, Zhaoyu; Wu, Yaping; Rajamanickam, Venkatesh; Bernard, Brady; Hilgart-Martiszus, Ian; Fountain, Christopher B; Morris, George; Iwamoto, Noriko; Shimada, Takashi; Chang, ShuChing; Traber, Peter G; Zomer, Eliezer; Horton, J Rex; Shlevin, Harold; Redmond, William L.
Afiliación
  • Curti BD; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Koguchi Y; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Leidner RS; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Rolig AS; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Sturgill ER; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Sun Z; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Wu Y; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Rajamanickam V; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Bernard B; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Hilgart-Martiszus I; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Fountain CB; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Morris G; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Iwamoto N; Shimadzu Bioscience Research Partnership, Shimadzu Scientific Instruments, Bothell, Washington, USA.
  • Shimada T; Shimadzu Bioscience Research Partnership, Shimadzu Scientific Instruments, Bothell, Washington, USA.
  • Chang S; Medical Data Research Center, Providence St Joseph Health, Portland, Oregon, USA.
  • Traber PG; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Zomer E; Galectin Therapeutics, Norcross, Georgia, USA.
  • Horton JR; Galectin Therapeutics, Norcross, Georgia, USA.
  • Shlevin H; Galectin Therapeutics, Norcross, Georgia, USA.
  • Redmond WL; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA william.redmond@providence.org.
J Immunother Cancer ; 9(4)2021 04.
Article en En | MEDLINE | ID: mdl-33837055
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Sanguíneas / Protocolos de Quimioterapia Combinada Antineoplásica / Pectinas / Galectinas / Anticuerpos Monoclonales Humanizados / Receptor de Muerte Celular Programada 1 / Carcinoma de Células Escamosas de Cabeza y Cuello / Inhibidores de Puntos de Control Inmunológico / Neoplasias de Cabeza y Cuello / Mieloma Múltiple Tipo de estudio: Diagnostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Sanguíneas / Protocolos de Quimioterapia Combinada Antineoplásica / Pectinas / Galectinas / Anticuerpos Monoclonales Humanizados / Receptor de Muerte Celular Programada 1 / Carcinoma de Células Escamosas de Cabeza y Cuello / Inhibidores de Puntos de Control Inmunológico / Neoplasias de Cabeza y Cuello / Mieloma Múltiple Tipo de estudio: Diagnostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos